Search - tctmd.com

Displaying 861 - 880 of 2772

Sort: Relevancy | Date

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Presenter: Kyle R. Lehenbauer

June 05, 2024

Presentation NY Valves 2024

Case Resolution

Presenter: Lauren Sharan Ranard

June 05, 2024

Presentation NY Valves 2024

When and How to Treat LVAD Associated Severe AR

Presenter: Gabriel Sayer

June 05, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Lauren Sharan Ranard

June 05, 2024

Presentation NY Valves 2024

Case Resolution

Presenter: Michael I. Brener

June 05, 2024

Presentation NY Valves 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Samir R. Kapadia

June 05, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Michael I. Brener

June 05, 2024

Presentation NY Valves 2024

Case Resolution

Presenter: Joseph Walsh

June 05, 2024

Presentation NY Valves 2024

Management of Acute Decompensated VHD With Cardiogenic Shock

Presenter: Thomas E. Waggoner

June 05, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Joseph Walsh

June 05, 2024

Presentation NY Valves 2024

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Presenter: Akshay Desai

June 05, 2024

Presentation NY Valves 2024

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

Presenter: Rahul Sawhney

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Presenter: Nirat Beohar

June 05, 2024

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

MicroRNA in Cardiac Transplantation: Biomarkers With Therapeutic Potential

Presentation THT 2024

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Presenter: Palak Shah

March 06, 2024

Advertisement

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Case Resolution

When and How to Treat LVAD Associated Severe AR

Case Presentation

Case Resolution

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Case Presentation

Case Resolution

Management of Acute Decompensated VHD With Cardiogenic Shock

Case Presentation

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Resolution of Chronic Respiratory Failure and Transfusion-Dependent Anemia After Percutaneous Mitral Paravalvular Leak Closure Following Recent Surgical Mitral Valve Replacement

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Main Results From The Step-hfpef Dm Trial

Principal Results from the RELIEVE-HF Trial

MicroRNAs in Cardiac Transplantation: Biomarkers with Therapeutic Potential

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content